| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/22/2023 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Stock Option (right to buy) | 2M | $0.30 | $585k | | 06/22/2023 |
| 06/08/2023 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (Right to Buy) | 35k | $1.26 | $44.1k | | 06/08/2023 |
| 06/09/2022 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (Right to Buy) | 30k | $7.02 | $210.6k | | 06/09/2022 |
| 06/07/2022 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Director Stock Option (right to buy) | 43k | $0.73 | $31.4k | | 06/07/2022 |
| 06/09/2021 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (Right to Buy) | 23.5k | $8.97 | $210.8k | | 06/09/2021 |
| 06/08/2021 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Director Stock Option (right to buy) | 40k | $6.80 | $272k | | 06/08/2021 |
| 06/17/2020 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (right to buy) | 23.5k | $12.10 | $284.4k | | 06/17/2020 |
| 06/08/2020 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Director Stock Option (right to buy) | 28.1k | $8.89 | $249.8k | | 06/08/2020 |
| 06/10/2019 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (right to buy) | 23.5k | $19.54 | $459.2k | | 06/10/2019 |
| 06/07/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Director Stock Option (right to buy) | 12.4k | $6.33 | $78.5k | | 06/07/2019 |
| 02/12/2019 | Gossamer Bio, Inc. | GOSS | Purchase | Common Stock | 7.2k | $16.00 | $115.2k | | 02/12/2019 |
| 01/11/2019 | IMMUNIC, INC. | VTL | Disposition | Stock Option (right to buy) | 1.6M | $6.30 | $10M | | 01/11/2019 |
| 01/11/2019 | IMMUNIC, INC. | VTL | Grant | Restricted Stock Units | 1.9M | $0.00 | $0 | | 01/11/2019 |
| 06/07/2018 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Director Stock Option (right to buy) | 18.4k | $10.28 | $189.2k | | 06/07/2018 |
| 01/03/2018 | IMMUNIC, INC. | VTL | Grant | Non-Qualifed Stock Option (right to buy) | 1.6M | $6.30 | $10M | | 01/03/2018 |
| 12/11/2017 | Jazz Pharmaceuticals plc | JAZZ | Exercise | Incentive Stock Option (right to buy) | 44.2k | $8.23 | $363.8k | | 12/11/2017 |
| 12/11/2017 | Jazz Pharmaceuticals plc | JAZZ | Exercise | Incentive Stock Option (right to buy) | 4.9k | $46.83 | $227.9k | | 12/11/2017 |
| 12/11/2017 | Jazz Pharmaceuticals plc | JAZZ | Exercise | Incentive Stock Option (right to buy) | 1.7k | $59.13 | $100k | | 12/11/2017 |
| 12/01/2017 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Director Stock Option (right to buy) | 30k | $4.73 | $141.9k | | 12/01/2017 |
| 08/07/2017 | Jazz Pharmaceuticals plc | JAZZ | Payment of Exercise | Ordinary Shares | 978 | $155.56 | $152.1k | | 08/07/2017 |
| 03/06/2017 | Jazz Pharmaceuticals plc | JAZZ | Payment of Exercise | Ordinary Shares | 1.8k | $132.81 | $238.1k | | 03/06/2017 |
| 03/02/2017 | Jazz Pharmaceuticals plc | JAZZ | Grant | Non-Qualified Stock Option (right to buy) | 24.3k | $136.18 | $3.3M | | 03/02/2017 |
| 03/02/2017 | Jazz Pharmaceuticals plc | JAZZ | Grant | Incentive Stock Option (right to buy) | 734 | $136.18 | $100k | | 03/02/2017 |
| 03/02/2017 | Jazz Pharmaceuticals plc | JAZZ | Grant | Ordinary Shares | 10k | $0.00 | $0 | | 03/02/2017 |
| 01/18/2017 | Jazz Pharmaceuticals plc | JAZZ | Sale | Ordinary Shares | 1000 | $125.00 | $125k | | 01/18/2017 |
| 01/18/2017 | Jazz Pharmaceuticals plc | JAZZ | Sale | Ordinary Shares | 3k | $130.00 | $390k | | 01/18/2017 |
| 05/17/2016 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Director Stock Option (right to buy) | 10k | $7.28 | $72.8k | | 05/17/2016 |
| 04/12/2016 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 7k | $10.00 | $70k | | 04/12/2016 |
| 09/04/2013 | Jazz Pharmaceuticals plc | JAZZ | Sale | Ordinary Shares | 1000 | $88.16 | $88.2k | | 09/04/2013 |
| 03/05/2013 | Jazz Pharmaceuticals plc | JAZZ | Grant | Incentive Stock Option (right to buy) | 1.7k | $59.13 | $100k | | 03/05/2013 |
| 03/05/2013 | Jazz Pharmaceuticals plc | JAZZ | Grant | Nonstatutory Stock Option (right to buy) | 25.8k | $59.13 | $1.5M | | 03/05/2013 |
| 03/05/2013 | Jazz Pharmaceuticals plc | JAZZ | Grant | Ordinary Shares | 13.8k | $0.00 | $0 | | 03/05/2013 |
| 10/01/2012 | Jazz Pharmaceuticals plc | JAZZ | Sale | Ordinary Shares | 5k | $57.24 | $286.2k | | 10/01/2012 |
| 05/31/2011 | Jazz Pharmaceuticals plc | JAZZ | Other (acquisition) | Common Stock | 208 | $14.89 | $3.1k | | 05/31/2011 |
| 03/10/2011 | Jazz Pharmaceuticals plc | JAZZ | Grant | Option (right to buy) | 40k | $27.46 | $1.1M | | 03/10/2011 |